Amundi
NVRO

Amundi’s NEVRO CORP. NVRO Stock Holding History

Amundi’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,534
Closed -$29.8K – 2254
2024
Q4 		$29.8K Buy
+8,534
New +$39.4K ﹤0.01% 1870

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amundi's NVRO Position: Q1 2025 in Review

Amundi sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 8,534 shares — an estimated $29.8K sold.

Amundi first reported a position in NVRO in Q4 2024 and held it in 1 quarter. The position peaked at $29.8K in Q4 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Amundi reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Amundi sold 8,534 NEVRO CORP. shares in Q1 2025, an estimated $29.8K.
  • Amundi first reported a position in NEVRO CORP. in Q4 2024 and held it in 1 quarter.
  • Amundi's NEVRO CORP. position peaked at $29.8K in Q4 2024.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.